Podcasts about outcomes

A study of more than 31,000 adults with Type 2 diabetes found that a widely prescribed class of blood pressure medications was associated with a 33% higher risk of serious kidney complications, including substantial loss of kidney function, dialysis or transplantation The increased kidney risk persisted even though all participants were already taking modern kidney-protective therapies that are considered standard treatment for diabetic kidney disease Researchers believe these medications may increase pressure inside the kidneys' filtering units, exposing already damaged tissue to additional mechanical stress, which may accelerate kidney decline High blood pressure not only raises the risk of heart disease but also damages the kidneys over time, making blood pressure control one of the most important strategies for preserving kidney function Improving blood sugar control, restoring a healthier sodium-to-potassium balance, reducing chronic stress, optimizing vitamin D levels, and staying physically active may help lower blood pressure naturally and reduce strain on the kidneys

Are we chasing a standard of excellence that today's healthcare system can realistically sustain? On this episode of KeyLIME+, Adam speaks with medical education leaders Drs. Farhan Bhanji and Damon Dagnone about the future of medical education and healthcare in Canada. They explore Competence by Design, the tension between certification and licensure, the physician workforce crisis, and the changing role of internationally trained physicians in Canada. As pressures mount on healthcare systems, regulators, and training programs, the conversation explores an important question: how should medical education evolve to meet the needs of learners, physicians, and patients in today's healthcare environment Episode Length:  47:48   Resources to check-out   John Norcini, Irina Grabovsky, Michael A Barone, M Brownell Anderson, Ravi S Pandian, Alex J Mechaber, The Associations Between United States Medical Licensing Examination Performance and Outcomes of Patient Care, Academic Medicine, Volume 99, Issue 3, March 2024, Pages 325–330, https://doi.org/10.1097/ACM.0000000000005480  Contact us: keylime@royalcollege.ca       Follow: Dr. Adam Szulewski https://x.com/Adam_Szulewski    

Today, we are tackling a massive grey area in obstetrics/maternal-fetal medicine: What happens after early fetal growth restriction resolves? When a baby bounces back on the growth chart during the second or third trimester, are they completely out of the woods? Or is there a hidden, lingering risk we aren't talking about enough? To find out, we're doing a deep dive into two major publications that dropped just this month, in August 2026 in sister journals (AJOG and AJOG MFM). Both are retrospective, both ask the exact same burning question…and get this: they arrive at completely opposing conclusions. How is that possible? Listen in for details. 1. Melamed B, Mei-Dan E, Aviram A. Sonographic fetal weight estimation percentiles should be interpreted with caution in the second trimester. Int J Gynaecol Obstet. 2026 May;173(2):930-939. doi: 10.1002/ijgo.70693. Epub 2025 Nov 25. PMID: 41288086.2. Ramos SZ, Has P, Gimovsky AC, Danilack VA, Savitz DA, Lewkowitz AK. Outcomes among Neonates after a Diagnosis of Persistent or Transient Fetal Growth Restriction Delivered at Term. Am J Perinatol. 2024 May;41(S 01):e1470-e1477. doi: 10.1055/a-2051-3859. Epub 2023 Mar 9. Erratum in: Am J Perinatol. 2024 May;41(S 01):e1478. doi: 10.1055/s-0044-1786526. PMID: 36894159; PMCID: PMC10562520.3. Keller N, Jackson F, Abelman S .Neonatal morbidity following resolution of fetal growth restriction diagnosed at second-trimester anatomy ultrasound. American Journal of Obstetrics & Gynecology MFM, 2026; Aug 8. 4. Cenac LA, Wodoslawsky S, Patel V, McLaren Jr. R, Aghai ZH, Makhamreh MM, Al-Kouatly HB, Persistent, Resolved, and Absent Fetal Growth Restriction: A Comparison of Neonatal Outcomes, American Journal of Obstetrics and Gynecology (2026), doi: https:// doi.org/10.1016/j.ajog.2026. Aug 19

As MTM evolves and pharmacies prepare for increased demand, what does success look like from both the technology side and the pharmacy operations side? Ross brings the perspective of innovation, workflow transformation, and MTM Intelligence. Jon brings the perspective of an independent pharmacy owner and operator who understands the realities of staffing shortages, prescription volume, patient expectations, and limited resources. The result is a conversation that feels less like a product discussion and more like an industry discussion about helping independent pharmacies thrive.   Guests: Jon Grice and Ross Frei  

The episode reveals a structural shift away from indiscriminate adoption of AI tools toward targeted deployment based on business needs within the MSP sector. According to Uptime Global, a channel-only outsourcing provider, premature or hype-driven implementation of AI frequently results in incomplete projects and missed operational gains. The review of AI execution within MSP ticketing environments shows that sustainable value emerges when organizations align AI initiatives with clearly identified business issues, rather than searching for use cases to justify a technology already acquired. Concrete evidence from Uptime Global's experience indicates that approximately 25% of their MSP partners have deployed notable AI solutions beyond ticket triage functions in the past 18 months, according to Jason Kemsley, Chief Revenue Officer. Outcomes vary: roughly half saw ticket volume reductions of 10–25%, while the remainder experienced limited value or customer dissatisfaction tied to inadequate human involvement in support processes. Uptime's operational model uses a confidence threshold for AI-driven actions, where only outputs above 98% confidence automatically execute—mirroring human engineer accuracy rates—and anything below triggers human review. Supporting developments further highlight the shift's operational impact. Uptime Global has eliminated dedicated triage and dispatch roles due to increased AI efficiency, resulting in a role blend where “first responders” now handle both traditional triage and basic technical support tasks within set time limits . The company's pricing structure is affected by AI efficiency, creating margin pressure as contract models based on per-ticket or per-device pricing are exposed to declining ticket volume and shifting customer expectations around service value and outcomes. For MSPs and IT service providers, the operational implications center on increased pricing pressure, the erosion of certain labor-based roles, and the requirement to redesign governance and accountability models to accommodate both automated and human ticket outcomes. Vendor dependency grows as MSPs rely on AI-driven platforms to triage, allocate, and resolve tickets, increasing exposure to platform-specific risks and necessitating clear thresholds for AI confidence and human intervention. Contract structures that do not account for dynamic efficiency gains may create pricing misalignment and customer dissatisfaction over time, emphasizing the need for providers to actively manage and transparently communicate both the tradeoffs and limits of AI-enabled support. Supported by:ProofpointScalePad

In Episode 271: The Outcomes Formula, I introduce a new coaching framework that represents a shift in the way I help missionaries and clients understand their thoughts, emotions, and actions. If you've listened to earlier episodes where I taught The Model, don't worry—I'm not throwing it out. Instead, I've simplified and refined the process into something I believe is more compassionate, more flexible, and easier to apply in everyday life. My hope is that this new approach helps you spend less time judging yourself and more time understanding what's really happening in your mind. Throughout this episode, I walk through each step of what I call The Outcomes Formula: Observation, Assessment, Feeling, Action, and Outcome. We explore how your brain naturally takes in information, assigns meaning to it, creates emotions, fuels your actions, and ultimately produces the outcomes you experience. Rather than focusing on whether your observations are perfectly factual, I explain why it's often more helpful to become curious about the meaning your brain is assigning to those experiences and how that meaning shapes the rest of the formula. If you've ever wondered why you keep getting stuck in the same emotional patterns, why anxiety or discouragement seem to repeat themselves, or how to interrupt those cycles with greater compassion and awareness, I hope Episode 271: The Outcomes Formula gives you a practical tool you can return to again and again. My hope is that this framework helps you better understand yourself, strengthen your emotional resilience, and recognize that lasting change begins with becoming aware of the stories your brain is telling you—not by trying to become someone different. As always, if you found this episode helpful, I want to invite you to subscribe if you aren't already, share this episode with your friends and missionaries you know, and write a review. I know this work will help LDS missionaries around the world and it would mean so much to me if you did. Until next week my friends.   00:00 – Introduction 00:54 – Why I'm Teaching a New Coaching Framework 03:30 – Introducing the Outcomes Formula 05:14 – Step 1: Observation (What You're Noticing) 08:11 – Step 2: Assessment (The Meaning Your Brain Creates) 10:57 – Steps 3 & 4: Feelings Fuel Your Actions 16:28 – Step 5: Outcomes and the Feedback Loop 19:49 – Why I Moved Beyond "The Model" 26:07 – Using the Outcomes Formula with Compassion Instead of Shame 29:34 – The Power of Changing Your Assessment   Website | Instagram | Facebook   5 Ways to Process Any Less-Than Happy Mission Memories Article: HERE   Get the Full Show Notes and Text/PDF Transcripts: HERE   Free PDF Download:  Podcast Roadmap   Free PDF Download:  Preparing Missionary Cheat Sheet   Free Training for Preparing Missionaries:  Change Your Mission with this One Tool   RM Transition Free Video Series:  3 Tools to Help RMs in Their Transition Home   Free Guide:  5 Tips to Help Any Returning Missionary   Schedule a Free Strategy Call:   Click Here

00:00- Just over 50 days until Sixers basketball! 03:05 - Best/Worst Outcome for VJ Edgecombe 12:09- Best/Worst Outcome for Tyrese Maxey 21:04 - Best/Worst Outcome for Joel Embiid 30:26 - Best/Worst Outcome for Jaylen Brown 36:41 - Best/Worst Outcome for LeBron James

Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Kushal Vaghani - Denbigh Pharmacy Kevin Boesen - Outcomes Gold Eneyo - Cencora Nic Bernabe - Outcomes Steven Dolan - Monroe Pharmacy Dalia Rios - Outcomes Christian Hampel - Family Prescription Counter

Shawn Gibbs is the co-founder and CEO, GIV Gowns. He is a medical provider and serial entrepreneur who spent 15 years on every side of healthcare, then built the system that designs trust into the care experience. Top 3 Value Bombs 1. Dignity comes before trust, and trust drives every meaningful outcome. When people feel genuinely valued and respected, they become more engaged, confident, and committed. 2. Trust must be designed intentionally; it doesn't happen by accident. Every interaction should communicate safety, respect, and genuine care from the very first moment. 3. Become the person you claim to be. Authenticity creates credibility, and consistent actions build the trust that customer and clients remember long after the interaction ends. Check out Shawn's website for training resources and educational content - Shawn Gibbs Website Sponsors HighLevel - The ultimate all-in-one platform for entrepreneurs, marketers, coaches, and agencies. Learn more at HighLevelFire.com. ThriveTime Show - Is your business stuck? Join Eric Trump and Clay Clark's life-changing business conference November 5th and 6th in Tulsa, Oklahoma. ThriveTimeShow.com/eofire.

The threat landscape has become more interconnected, disruptive, and complex. Ransomware is now as much about extortion and data theft as it is about encryption. Supply chain events can create outages that ripple far beyond the initial target, and business interruption increasingly comes from third-party and cloud dependencies. How should CISOs prepare for these scenarios? Dan Bowden, Global Business CISO at Marsh, joins Business Security Weekly to discuss how to connect cyber risk to the outcomes boards care about most: resilience, financial exposure, regulatory impact, and reputation. CISOs need to position cyber as an enterprise risk, not a technical risk, that can be measured, prioritized, and managed alongside other strategic risks. Dan will discuss the results of Marsh's Cyber Catalyst research and Global Cyber Claims Report. Visit https://securityweekly.com/infosecworld2026 and save 30% on your ISW pass with code: ISW26-SWSAVINGS The Agent Is the New Insider: Why Human Risk Doesn't Stop at People: Black Hat Interview with Leslie Nielson, CISO at Mimecast AI agents now act with the same credentials and access as the humans who deployed them, but without the judgment or accountability that comes with actual employment. Mimecast CISO Leslie Nielsen argues that treating agentic AI as a brand new, standalone security category is the wrong instinct: agents are an extension of human risk, and the controls organizations already use to manage people are the right foundation for managing machines. In this conversation, Nielsen unpacks the growing gap between security leaders who expect AI driven attacks and those who feel prepared for them, and what that gap means for CISOs walking the floor at Black Hat. Segment Resources: Mimecast's new whitepaper Securing The Agentic Enterprise: https://assets.mimecast.com/api/public/content/securing-the-agentic-enterprise?v=ea66db05 Mimecast's landing page for thought leadership resources: https://www.workprotected.com/ Mimecast's State of Human Risk Report: https://www.mimecast.com/resources/ebooks/state-of-human-risk/ Mimecast's Threat Intelligence Hub: https://www.mimecast.com/threat-intelligence-hub/ For more information about Mimecast please visit: https://securityweekly.com/mimecastbh Ransomware Moves up the Org Chart: Managers Are Prime Targets: Black Hat Interview with Brett Stone-Gross, Sr. Director, Threat Intelligence at Zscaler When a ransomware attack makes headlines, attention usually turns to the organization that was breached, the systems encrypted, data stolen, and disruption or ransom demand that followed. Less, if anything, is revealed about the employees compromised at the start of the attack, and what makes those individuals valuable targets. New Zscaler ThreatLabz research examines this early stage of a real-world ransomware attack. ThreatLabz identified victims of a campaign associated with a ransomware group known for gaining initial access, stealing large amounts of corporate data, and selectively encrypting critical systems. The findings show who those victims were and how their roles and authority could help an attacker move deeper into an organization. This is part of ongoing ransomware research by ThreatLabz. The Zscaler ThreatLabz 2026 Ransomware Report, coming in the next two months, will include additional data on ransomware victims, the latest ransomware trends, targets, and tactics, and the risks enterprises should prepare for next. This segment is sponsored by Zscaler. Visit https://securityweekly.com/zscalerbh to learn more about them! Visit https://www.securityweekly.com/bsw for all the latest episodes! Show Notes: https://securityweekly.com/bsw-462

Gain actionable strategies to support more inclusive, culturally responsive, and family-centered practice.Guest: Samantha Dudding, MS, CCC-SLPEarn 0.10 ASHA CEUs for this episode with Speech Therapy PDWatch on YouTubeIn this episode of First Bite, Michelle Dawson, MS, CCC-SLP, CLC, is joined by Samantha Dudding, MS, CCC-SLP, for a thoughtful conversation about how culturally responsive communication can promote more equitable outcomes in special education. Drawing on her clinical expertise and leadership experience, Samantha shares practical strategies for supporting culturally and linguistically diverse students and families while strengthening collaboration across educational teams.About the Guest: Samantha Dudding, M.S., CCC‑SLP, is a speech‑language pathologist and special education leader whose work centers on culturally responsive communication within school‑based special education processes. She is currently a Student Support Coordinator in a school district just outside of Washington, DC where she facilitates special education processes, supports multidisciplinary teams, and leads professional development focused on inclusive practices.Show Notes:Bronfenbrenner's ecological systems theorySign up for the ASHFoundation's 7th Annual Virtual Walk/RunJoin the team "First Bite Fun Runners"

Are you prepared for your next endoscopy, or ready to review a legal case involving procedural sedation? In this episode of the Legal Nurse Podcast, Pat Iyer is joined by experienced critical care nurse Tracey Kappers to explore the complexities of IV sedation, particularly in the endoscopy suite. Tracey Kappers draws on her deep clinical background to reveal why sedation is far from routine and highlights the risks and responsibilities facing healthcare professionals. Together, Pat Iyer and Tracey Kappers discuss the importance of careful patient assessment, the roles of different medication providers, and the standards of care that must be met to ensure safety. They address the real-world scenarios that legal nurse consultants might be asked to review, cases that hinge on documentation, patient selection, and rapid response to emergencies in the procedure room. Whether you're a legal nurse consultant, a healthcare provider, or simply someone facing a future colonoscopy, this episode offers essential insights into procedural sedation, the medications involved, possible complications, and the critical safeguards every facility must follow. Listen in for expert advice and stories that underscore the high stakes in seemingly routine medical procedures. What You'll Learn in This Episode on Sedation Safety: Avoiding Catastrophic Outcomes in Outpatient Procedures Here are 5 discussion questions answered in the podcast: What are the key differences between moderate and deep sedation in procedural settings, and why is it critical that the person performing a procedure not also be the one administering and monitoring sedation? In which healthcare environments besides endoscopy suites can patients receive procedural sedation, and what unique risks might these settings pose? How does the ASA (American Society of Anesthesiologists) physical status classification system affect patient eligibility for outpatient procedural sedation? What responsibilities do nurses hold when assessing a patient's suitability for sedation, and how should they handle ambiguous or borderline assessments? How can disagreements or communication failures between providers and nurses regarding verbal medication orders impact patient safety and legal outcomes? Get the free transcripts and also learn about other ways to subscribe. Go to Legal Nurse Podcasts subscribe options by using this short link: http://LNC.tips/subscribepodcast. https://youtu.be/G7bOZqwSyRI Your Presenter for Sedation Safety: Avoiding Catastrophic Outcomes in Outpatient Procedures Pat Iyer Pat Iyer is a seasoned legal nurse consultant and business coach, renowned for her expertise in guiding new legal nurse consultants to successfully break into the field. As the host of the Legal Nurse Podcast, Pat addresses critical challenges that legal nurse consultants face, such as difficulty in landing clients and a lack of response from attorneys. Through her insightful episodes, she emphasizes the importance of effectively communicating one's value to potential clients. With a wealth of experience, Pat has empowered countless consultants to overcome these hurdles and thrive in their careers. Connect with Pat Iyer by email at patiyer@legalnusebusiness.com Tracey Kappers IV sedation nurse expert, legal nurse consultant, scuba diver, and travel enthusiast. I began my career in high-acuity trauma ICU, cardiac critical care nursing, and recovery room, with experience in GI endoscopy and procedural sedation recovery. I now work with attorneys through TKO Consulting, reviewing medical records and translating complex clinical details into clear timelines and insights that support case strategy. My work focuses on identifying what happened clinically, what should have happened, and where breakdowns occurred in patient care. With a background spanning ICU trauma care, procedural sedation, and outpatient recovery, I bring a practical clinical perspective to legal cases involving medical injury. When she is not on this podcast, she is scuba diving in some of the world's most memorable waters or spending time with her family and planning her next travel adventure. Connect with Tracey Kappers by email at traceykappers@tkolncconsulting.com

The Police and Prisons Civil Rights Union, POPCRU says ActionSA's court bid to review disciplinary outcomes for two Presidential Protection Service officers must not turn Major-General Wally Rhoode and Brigadier Hennie Rekhoto into political targets. The union says approaching the High Court is a constitutional right, but guilt cannot be assumed before a court rules. Popcru adds that all SAPS members are entitled to due process, legal representation and the presumption of innocence, regardless of political pressure around the Phala Phala matter. We spoke to POPCRU President Thulani Ngwenya

Fitness trackers have exploded in popularity, and wearable users swear by the data. But psychologists say these devices can lead to anxiety and obsession. Endlessly checking sleep scores and step counts is part of the problem, but the bigger concern is that even favorable numbers don't mean we're actually healthy. Adam Clark Estes, senior technology correspondent for Vox, did his own fitness tracking experiment, and Dr. Thea Gallagher is a psychologist who works with patients with obsessive disorders. They'll join us to talk about what's driving our desire to quantify our lives, and how we can get better at using tech to support our physical and mental health. Guests: Dr. Thea Gallagher, clinical associate professor, Department of Psychiatry at NYU's Grossman School of Medicine; Digital Mental Health, Outcomes, and Wellness Coordinator at NYU Langone Health; licensed clinical psychologist and anxiety specialist Adam Clark Estes, senior technology correspondent, Vox Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from:   Scott Lake - Rx.co Kaley Lester - Outcomes Nicholas Turos - Cencora Janet Parrish - Adair Drug; Colombia, KY Kaushal Patel - Apollo Pharmacy; Savannah, GA Bianca Bradshaw - Elmore Pharmacy; Red Bluff, CA Zackary Levine - Cencora

FAILURE IS AN OPTION: Silicon Valley CEO Mike Grossman Reveals the Truth About SuccessWhat does entrepreneurship really look like when you remove the highlight reel?On this episode of Diversified Game, Kellen Coleman, M.A. sits down with Silicon Valley entrepreneur, six-time CEO, author, and former McKinsey consultant Mike Grossman, author of Failure Is an Option: Reflections of a Silicon Valley CEO.Mike breaks down the side of entrepreneurship people rarely post online: failure, bad timing, mental pressure, investor expectations, legal mistakes, family sacrifice, luck, and the difference between a good process and a good outcome.He shares how one company reached about a $30 million run rate before Congress changed the rules around its business model, while another company facing a disrupted IPO during COVID was unexpectedly acquired for roughly $400 million.The conversation also covers when entrepreneurs should quit or pivot, why “hope isn't a strategy,” how acting as his own lawyer nearly cost Mike millions, why ownership matters, how his wife helped make his entrepreneurial career possible, and why many CEOs struggle privately with mental health.• Control effort and process, not outcomes.• Failure does not automatically mean incompetence.• Know when persistence becomes denial.• Hire experts where your expertise ends.• Ownership and long-term thinking matter.• Entrepreneurship is emotional as well as financial.• Never confuse the Silicon Valley highlight reel with reality.03:01 Mike introduces Failure Is an Option05:51 Outcomes vs. effort07:00 The $400M acquisition10:06 Hope isn't a strategy15:20 Mike's four tests before starting a company27:34 His biggest business mistake34:59 Ownership, debt and long-term wealth38:19 Marriage and entrepreneurship45:59 CEOs and mental health52:50 Focus on what you can controlMike GrossmanBook: Failure Is an Option: Reflections of a Silicon Valley CEOWebsite: https://FailureIsAnOption.comLearn the mindset and moves that lead to real results. Please visit my website to get more information: http://diversifiedgame.com/

As US video ad spend reaches $82 billion, media buyers are demanding granular audience targeting capabilities alongside bottom-funnel performance metrics. IAB Vice President Chris Bruderle breaks down the shifting dynamics between CTV and social video, the rise of multimodal contextual AI, and why live sports platforms must prove direct ROI to capture long-tail budgets. Key Highlights

Send us Fan Mail Not everything has to work out perfectly to still count. In this episode, I'm exploring what happens when we stop grading every experience by the outcome and start allowing life to teach us through the process instead.From motherhood and running to creativity, regret, and everyday decisions, this is a conversation about loosening our grip on results. If you've ever labeled something a failure, a waste of time, or not worth it simply because it didn't end the way you hoped, this episode will help you see those experiences differently.What You'll Learn:Why outcomes don't determine whether an experience matteredHow hindsight can distort the way we judge past decisionsWhy presence grows when we stop constantly evaluating ourselvesKey Takeaways:Not every experience needs immediate meaningWhat feels wasted may still be shaping youLess judgment creates more room to actually liveCall to Action:Choose one experience you've been labeling as a failure, waste of time, or wrong turn. Instead of judging the outcome, ask yourself what you experienced, learned, or discovered along the way. You don't have to force a lesson or make it mean something yet. Let the experience simply count.Listen on: Apple Podcasts, Spotify, and more.______________________________You can find me here:Instagram: @gingerbizWebsite: https://www.katymurrayphotography.com/Facebook: https://www.facebook.com/groups/TipsandTricksforyourbusinessX: https://twitter.com/GingerBizKMLinkedIn: https://www.linkedin.com/in/katy-murray-ginger-biz/ 

CardioNerds (Drs. Dr. Natalie Marrero, Dr. Ritika Tuli, and Dr. Rafael Toro Manotas) discuss multimodality imaging for risk stratification, evaluation, and management of chronic coronary artery disease with Dr. Panithaya Chareonthaitawee. Audio editing by CardioNerds intern Iman Razeghian. This episode was produced as part of the CardioNerds Academy curriculum by House Taussig under the guidance of House Chief, Dr. Natalie Marrero and Academy Program Director, Dr. Gurleen Kaur. A matching review article will be published in US Cardiology Review, the official journal of CardioNerds. This discussion was planned in collaboration with the Mayo Clinic Cardiovascular Board Review Course. In this episode, we discuss the pathophysiology and risk stratification of chronic coronary artery disease (CAD), as well as the current landscape of non-invasive evaluation of this condition. CAD remains a leading cause of morbidity and mortality despite advances in pharmacological and non-pharmacological strategies for the prevention and treatment of atherosclerotic disease. The concept of chronic CAD has shifted from the traditional model of stable, obstructive, flow-limiting disease, toward the current understanding of a dynamic process that extends beyond obstructive epicardial lesions to include non-obstructive plaque, diffuse atherosclerosis, and microvascular disease. Similarly, the imaging modalities used to evaluate CAD have evolved, and clinicians now have an extensive menu of options, each with distinct advantages and limitations, that must be selected carefully to maximize diagnostic accuracy and optimize treatment guidance, while also considering resource availability, local expertise, and high-value care. By the end of the episode, listeners will understand the pathophysiology of chronic CAD, risk-stratify patients with suspected CAD, recognize the advantages and pitfalls of each non-invasive diagnostic modality, and select the most appropriate diagnostic tool for a given clinical scenario. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls: Chronic CAD is a complex process that extends beyond obstructive epicardial stenosis to include non-obstructive disease, dynamic plaque burden and ischemia, diffuse atherosclerosis, microvascular dysfunction, vasospasm, among others. When evaluating patients with suspected CAD, the diagnostic process should be guided by a specific and appropriate clinical question before ordering any tests. The current diagnostic tool arsenal is broadly divided into anatomic and functional imaging modalities. These are complementary, each with distinct properties and limitations, addressing different clinical questions and assessing different aspects of disease. Local availability and expertise, along with patient-specific considerations and contraindications, determine the choice of diagnostic modality. No single test is best for every patient. INOCA and coronary microvascular dysfunction represent a common and increasingly recognized entity that is diagnosable and treatable; initial evaluation includes non-invasive testing such as stress PET and stress CMR. References Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368-e454. doi:10.1161/CIR.0000000000001029 https://pubmed.ncbi.nlm.nih.gov/34709879/ Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415-3537. doi:10.1093/eurheartj/ehae177 https://pubmed.ncbi.nlm.nih.gov/39210710/ Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148(9):e9-e119. doi:10.1161/CIR.0000000000001168 https://pubmed.ncbi.nlm.nih.gov/37471501/ Edvardsen T, Asch FM, Davidson B, et al. Non-Invasive Imaging in Coronary Syndromes: Recommendations of The European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration with The American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2022;35(4):329-354. doi:10.1016/j.echo.2021.12.012 https://pubmed.ncbi.nlm.nih.gov/35379446/ Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372(14):1291-1300. doi:10.1056/NEJMoa1415516 https://pubmed.ncbi.nlm.nih.gov/39210710/ Sharma A, Coles A, Sekaran NK, et al. Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease. J Am Coll Cardiol. 2019;73(8):893-902. doi:10.1016/j.jacc.2018.11.056 https://pubmed.ncbi.nlm.nih.gov/30819356/ SCOT-HEART Investigators, Newby DE, Adamson PD, et al. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med. 2018;379(10):924-933. doi:10.1056/NEJMoa1805971 https://pubmed.ncbi.nlm.nih.gov/30145934/ Li Z, Xu T, Wang Z, et al. Prognostic Significance of Computed Tomography-Derived Fractional Flow Reserve for Long-Term Outcomes in Individuals With Coronary Artery Disease. J Am Heart Assoc. 2025;14(2):e037988. doi:10.1161/JAHA.124.037988 https://pubmed.ncbi.nlm.nih.gov/39791423/ Bateman TM, Al-Mallah MH, et al. Clinical indications for positron emission tomography myocardial perfusion imaging and myocardial blood flow quantification: An American Society of Nuclear Cardiology position statement. J Nucl Cardiol. 2026;57:102619. doi:10.1016/j.nuclcard.2025.102619 https://pubmed.ncbi.nlm.nih.gov/41482140/ Taqueti VR, Di Carli MF. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72(21):2625-2641. doi:10.1016/j.jacc.2018.09.042 https://pubmed.ncbi.nlm.nih.gov/30466521/ Taqueti VR, Hachamovitch R, Murthy VL, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131(1):19-27. doi:10.1161/CIRCULATIONAHA.114.011939 https://pubmed.ncbi.nlm.nih.gov/25400060/ Mehta PK, Huang J, Levit RD, Malas W, Waheed N, Bairey Merz CN. Ischemia and no obstructive coronary arteries (INOCA): A narrative review. Atherosclerosis. 2022;363:8-21. doi:10.1016/j.atherosclerosis.2022.11.009 https://pubmed.ncbi.nlm.nih.gov/36423427/ Kunadian V, Chieffo A, Camici PG, et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. EuroIntervention. 2021;16(13):1049-1069. doi:10.4244/EIJY20M07_01 https://pubmed.ncbi.nlm.nih.gov/32624456/

CardioNerds (Dr. Apoorva Gangavelli, Dr. Cory Sejo, and Dr. Joseph Kassab), discuss tricuspid regurgitation evaluation and management with Dr. Sunil Mankad. This episode was produced as part of the CardioNerds Academy curriculum by House Einthoven under the guidance of House Chief, Dr. Apoorva Gangavelli and Academy Program Director, Dr. Gurleen Kaur. A matching review article will be published in US Cardiology Review, the official journal of CardioNerds. This discussion was planned in collaboration with the Mayo Clinic Cardiovascular Board Review Course.  Audio editing by CardioNerds intern Emma Winakur. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Key Points: Tricuspid regurgitation is common and associated with increased mortality at every stage, regardless of etiology. Outcomes are worse with worsening severity, so accurate grading is critical. Etiology is critical to guide treatment decisions. Etiology includes primary vs secondary (atrial or ventricular) vs CIED-related TR. 3D echocardiography can be very helpful in determining TR etiology, especially in CIED-related TR. Diuresis with the goal of euvolemia is step one. Additionally, underlying contributory conditions (eg. pulmonary HTN, HFrEF, atrial fibrillation) should be addressed, if appropriate, and then TR severity reassessed. The choice between T-TEER and TTVR hinges on anatomy, RV function, pulmonary hypertension, and the ability to tolerate anticoagulation. T-TEER is generally first line in atrial functional TR with appropriate anatomy, in patients with poor RV function who cannot tolerate a sudden increase in RV afterload, or in patients who cannot tolerate the necessary anticoagulation with TTVR. TTVR is preferred with wide coaptation gaps and CIED-related TR. This is a team sport. Multidisciplinary discussions utilizing imaging (TTE/TEE, CT), risk scores (TRI-SCORE or TRIO), patient preference, and prior institutional experience are essential for the effective treatment of severe TR. Notes: What is the clinical importance of tricuspid regurgitation? TR is very common with approximately 4% of people over 75 having moderate or greater severity. TR (even mild) is associated with increased mortality. Those outcomes worsen as the TR severity worsens, and this phenomenon is independent of the mechanism of regurgitation. What is unique about the tricuspid valve compared to the other cardiac valves? It is at an anterior location which allows it to be imaged well with transthoracic echocardiography It is the largest valve and composed generally of 3 leaflets (but very often can have 4+ leaflets). Importantly, the RV is compliant and changes size and shape readily based on loading conditions. The TV annulus similarly changes size and shape based on hemodynamic conditions such as preload. What is a good framework for approaching the causes of tricuspid regurgitation? Determine the presence and define the severity of TR. Using TTE, we want to measure the right atrial size, the RV size, and any other concomitant valvular lesions.  Use TTE (2D and 3D) to characterize leaflet anatomy and characteristics. Subtypes of TR mechanisms (many times etiology is mixed). Primary: primary leaflet abnormality, occurs in ~10% of cases. Look for prolapse, flail, endocarditis, etc. Secondary/functional: leaflets normal but surrounding structures are abnormal. Atrial: RA and tricuspid annular dilation but normal RV size/shape, and can be related to arrhythmias like atrial fibrillation. Ventricular: RV dilated and/or dysfunctional with leaflet tethering. Can be related to pulmonary hypertension or primary RV disease. Cardiac implantable electronic device (CIED): Related to device (usually pacemakers or ICD) interaction with TV leaflets. Includes perforation, entanglement in subvalvular apparatus, impingement, etc. 3D TTE particularly helpful to evaluate How do we grade TR severity? It is very important to grade the severity of TR, and this is generally done with echocardiography. There are both quantitative and qualitative methods which use Doppler and various equations to estimate TR severity. Current recommendations have expanded TR severity beyond mild/moderate/severe to include “massive” and “torrential” categories. The most important parameters measured/calculated are vena contracta width, regurgitant volume, regurgitant fraction, and effective regurgitant orifice area. Helpful qualitative metrics include hepatic venous flow reversal. When should additional studies beyond transthoracic echocardiography, such as transesophageal echocardiography (TEE), cardiac computed tomography (CT), and cardiac magnetic resonance imaging (MRI) be pursued? TEE is particularly helpful if TTE views are poor. Since TEE is used during transcatheter intervention, a pre-procedure TEE to define anatomy, determine procedure candidacy, and plan for the procedure is critical.  CT is also helpful for procedure planning and has particular strengths in defining annulus size and geometry. A CT is required prior to transcatheter tricuspid valve replacement (TTVR). MRI is helpful for measuring RV volumes and function, but is not generally used to assess TR severity.  What is the approach to the treatment for severe tricuspid regurgitation? The first step is to try to determine the etiology. For secondary TR, treating the underlying condition is indicated. For example, pulmonary vasodilators for pulmonary HTN or guideline therapy for heart failure with reduced ejection fraction. Diuretics are the mainstay for treatment, with the goal to obtain euvolemia. This may require inpatient admission to optimize volume status and medication regimen. Once reversible etiologies are addressed, if the patient is still symptomatic from TR, additional therapies can be considered. What is the role of right heart catheterizations (RHC) in patients with severe TR? RHC is very helpful for many reasons. We use it in TR to help determine volume status, cardiac output, and RV function. Additionally, identifying and characterizing pulmonary hypertension (with pulmonary artery pressures and calculating pulmonary vascular resistance) is an important factor when choosing future therapies.  With severe tricuspid regurgitation, when should we refer for intervention (either with surgery or transcatheter repair or replacement)? Once reversible etiologies are addressed and euvolemia has been achieved, if the patient is still symptomatic from TR despite aggressive medical optimization, additional therapies can be considered. Once euvolemic, a repeat TTE should be ordered to reassess the severity of the TR. Use calculators (for example, either the TRI-SCORE or TRIO score) to predict operative mortality for isolated TR surgery. What are our transcatheter treatment options in severe tricuspid regurgitation, and how do we choose between them? The primary approved transcatheter treatment options for severe TR include transcatheter tricuspid edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement (TTVR), of which the Edwards EVOQUE valve is the only one currently approved by the FDA. There are other TTVR device under investigation. These decisions should be made with a multi-disciplinary team including representation from cardiac imaging, interventional cardiology, and cardiothoracic surgery. Factors that go into the decision between T-TEER and TTVR include anatomy (annulus width, coaptation gap, leaflet length), RV reserve, pulmonary hypertension presence, ability to tolerate anticoagulation, patient preference, and institutional experience.  T-TEER is generally the first line with atrial functional and suitable anatomy. It is successful at reducing TR but does not generally eliminate it.  TTVR with EVOQUE is preferred in certain anatomic considerations like a large coaptation gap or when there is CIED-related TR (as this was excluded in T-TEER trials). Patients must be suitable for anticoagulation to receive TTVR as there is risk of leaflet thrombosis without it. If moderate/severe pulmonary hypertension is present, or there is poor RV function, TTVR may be avoided as the sudden elimination of TR causes a sudden increase in RV afterload which may not be tolerated. What is the role in advanced metrics for evaluating RV function? Advanced metrics like RV/PA coupling are under investigation but have not made it into the guidelines. The clinical utility is not yet known.  Assessing the RV function is important as stated above. Dr. Mankad prefers using 3D TTE to calculate an RVEF, or tracking RV longitudinal free wall strain. If you do encounter CIED-related TR, how do you treat it? Evaluate with TTE or TEE. 3D is very helpful to identify relative anatomy and leaflet-device interactions. There is no clear consensus about treatment if CIED-related TR is the primary mechanism of severe TR. If recently implanted, repositioning may be a valid option, but requires discussions with multiple teams including electrophysiology, advanced cardiac imaging, CT surgery, and interventional cardiology. References O’Gara PT, Lindenfeld J, Hahn RT, et al. 10 Issues for the Clinician in Tricuspid Regurgitation Evaluation and Management: 2025 ACC Expert Consensus Decision Pathway. J Am Coll Cardiol. 2025;S0735-1097(25)07047-0. O’Gara PT, Little SH, Badhwar V, et al. Operator and Institutional Recommendations and Requirements for Tricuspid Interventions: 2026 ACC/AHA/ASE/HRS/STS Expert Consensus Systems of Care Document. J Am Coll Cardiol. 2026;S0735-1097(26)05481-1. Hahn RT. Tricuspid Regurgitation. N Engl J Med. 2023;388(20):1876-1891. Davidson LJ, Tang GHL, Ho EC, et al. The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association. Circulation. 2024;149(22):e1223-e1238.

Show notes at pharmacyjoe.com/episode1156 In this episode, I'll discuss the effect of high-dose versus standard-dose influenza vaccines on hospitalization outcomes and mortality in older adults.

Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Ross Frei - Outcomes Ana Jimenez - Farmacia Las Americas, West Palm Beach, FL Todd Pendergraft - Broken Arrow Family Drug APA, Broken Arrow, OK Justin Erro - Medzoomer Nick DeSouza - Outcomes Jevic Dunn - Outcomes

MichaelAaron and Richard explore why half of chronic-illness patients skip their medication, and why scaring them into compliance backfires. They cover a study on avoiding bad medical news, a simple diagram that cut medication errors in half, and two studies showing doctors are swayed by menu order and time of day when prescribing.

How do you value a memory semiconductor stock like SK Hynix when no one can predict DRAM prices? Equity analyst Shan Rui Yeo walks through the team's Monte Carlo valuation framework: a discounted cash flow run through thousands of scenarios that prices the business on a distribution of returns rather than a single forecast. He also explains how two-times leveraged single-stock ETFs have been amplifying SK Hynix's daily price swings, why regulators and Korean brokers are responding to retail leverage, and why flow-driven volatility can be a gift for long-term investors. The through-line: memory can be cyclical, structurally growing, and wealth-creating all at once. 0:00 - Introduction & Disclaimer 0:21 - How Do You Value a Memory Stock Amid Huge Uncertainty? 0:54 - Monte Carlo Valuation: Pricing SK Hynix on a Distribution of Outcomes 5:27 - Day-to-Day Volatility: Fundamentals or Flows? 6:17 - How 2x Leveraged Single-Stock ETFs Amplify SK Hynix Price Swings 9:40 - What Investors Underappreciate About the Memory Industry 10:21 - Closing Thoughts & Subscribe Key Takeaways Key uncertain variables (DRAM prices, supply response, China risk) are modelled as ranges and run through thousands of scenarios; the output is a distribution of returns, treated stochastically. SK Hynix scenarios: bull (prices hold through the decade), realistic (decline from 2028 as supply arrives), bear (accelerated decline on over-investment and Chinese supply). The test is being paid adequately across the whole distribution, not picking the right scenario; the distribution centred around 12% with positive skew. New data points (LTAs signed, capacity expansion) update the distributions; position sizing follows the shape, and the team trimmed as the shares ran. Two-times leveraged ETFs rebalance by buying after rises and selling after falls, amplifying 10 to 15% daily moves in SK Hynix. Flow-driven volatility widens the gap between price and value, which long-term investors can use. Memory can be cyclical, structurally growing, and wealth-creating at the same time. Host: Rob Campbell, CFA, Institutional Portfolio Manager Guest: Shan Rui Yeo, CFA, Equity Analyst This episode is available for download anywhere you get your podcasts. Founded in 1974, Mawer Investment Management Ltd. (pronounced "more") is a privately owned independent investment firm managing assets for institutional and individual investors. Mawer employs over 250 people in Canada, U.S., and Singapore. Visit us at: https://www.youtube.com/@MawerInvestment https://www.mawer.com https://www.linkedin.com/company/mawer-investment-management/ https://www.instagram.com/mawerinvestmentmanagement/ #ArtOfBoring #MawerInvestmentManagement #MawerInvestment #Podcast #Finance #Investing #semiconductor #tech #techexplained #memory #skhynix

Send us Fan MailParents of babies undergoing therapeutic hypothermia often wait days before they can hold their child, and many never get the chance during cooling at all. This week on Journal Club, Daphna reviews a new Journal of Perinatology retrospective cohort from two level IV NICUs, 379 infants with HIE, where 28% were held during cooling. Held infants reached full oral feeds sooner, were more likely to go home on breast milk, and had shorter stays, but they were also less sick to begin with. Ben pushes on confounding, on the exclusion of infants who died, and on what equipment would make holding routine.----Association of parental holding during therapeutic hypothermia and NICU outcomes for infants with hypoxic-ischemic encephalopathy. Nguyen TT, Glass HC, Chan N, Taketa E, Pineda R, Cornet MC, Miller MJ.J Perinatol. 2026 Jun 22. doi: 10.1038/s41372-026-02753-3. Online ahead of print.PMID: 42332041Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

A bit late, sorry.

Socially vulnerable Medicare patients see dramatically better outcomes—such as fewer emergency department visits, fewer preventable hospital admissions, and 23.4% to 30% less use of high-risk medications—when their physicians take on full financial risk for their care compared with those in traditional fee-for-service Medicare. That's the core finding of a new study published in the June issue of Population Health, Equity & Outcomes, and the subject of this conversation between Ken Cohen, MD, chief medical officer for Optum Health, and host Sophia Humphreys, PharmD, vice president of health system strategy and innovation at The American Journal of Managed Care.

Everyone has read about how much productivity AI can have for federal applications. That allure can lead you into a situation where you may not be as prudent as you should be. Today, we sat down with Jamie Holcomb, COO of Electrosoft, and Steve Riley, VP and Field CTO of Netskope, to better understand how to balance the promise of AIAI with practical application in the federal government. Steve Riley has looked at federal technology projects, and he thinks that the government must get out of their pilots and into operations, measuring results and impact that is meaningful to the taxpayer. They highlight the rapid advancements in AI, noting that government agencies struggle to keep pace with commercial innovation. Riley thinks agents are great for gathering, assimilating, and assessing information.  It is probably not time for them to have independent agency. A survey reveals that 78% of federal leaders believe AI tools should be managed like users or devices within zero trust frameworks. Only 31% of federal IT leaders have high visibility into public AI tools. Because of Jamie Holcomb's experience at the United States Patent and Trademark Office, he thinks success comes down to action, not architecture.  From his view, agencies need timely intelligence connected directly to operational decisions. The conversation emphasizes the need for federal agencies to balance innovation with security, particularly in predictive AI and zero trust strategies, and to prioritize AI discovery and integration.  

In this episode, Dr. Grant Stucki discusses something many oral and maxillofacial surgeons experience but rarely talk about: the emotional weight of caring for patients who are in pain, injured, or facing life-changing diagnoses. He explores how repeated exposure to trauma can lead to compassion fatigue, emotional detachment, and secondary traumatic stress, with effects that often extend beyond the workplace into personal relationships. Dr. Stucki also examines the concept of moral injury, describing what happens when surgeons know the right course of action but feel constrained by the realities of the healthcare system. While emotional distancing can be a necessary way to stay focused during difficult cases, he explains that it can gradually develop into cynicism if left unaddressed. Throughout the episode, he encourages surgeons to move beyond the culture of simply "pushing through," recognize the emotional challenges of the profession, and seek support through honest conversations and connection.Key Points From This Episode:What listeners can expect from today's episode with Dr. Stucki.He unpacks some research findings closely related to today's topic of discussion.What makes emotional distancing dangerous to practitioners. Dr. Stucki breaks down compassion fatigue and its effects on practitioners. He looks at another important concept: secondary traumatic stress.How the concept of second victim syndrome works and why it matters.Different experiences surgeons may have after facing serious complications.A classic burnout domain and protective mechanism: depersonalization.Suffering a moral injury: functioning in a broken system. Dr. Stucki explains some of the recurring long-term changes that show up in practitioners. Why this conversation is important. Honest questions practitioners should be asking.He shares steps practitioners can take to bring healing to the healers. Links Mentioned in Today's Episode:‘Second Victim Syndrome Among Healthcare Professionals: A Systematic Review of Interventions and Outcomes' – https://pmc.ncbi.nlm.nih.gov/articles/PMC12145115/‘From Moral Injury Vulnerability to Protective Equity: The Voyage Every Surgeon Must Take' – https://pubmed.ncbi.nlm.nih.gov/39692009/‘Moral injury: An unspoken burden of transplant surgery'  – https://pubmed.ncbi.nlm.nih.gov/39159721/‘Surgeons' Emotional Experience of Their Everyday Practice - A Qualitative Study'  – https://pmc.ncbi.nlm.nih.gov/articles/PMC4657990/‘Surgeon Burnout and Relationships: A Missing Component in the Ongoing Conversation' – https://pmc.ncbi.nlm.nih.gov/articles/PMC11803599/Jim Rohn — https://www.jimrohn.com/ Rachel Hollis — https://msrachelhollis.com/ Everyday Oral Surgery Website — https://www.everydayoralsurgery.com/ Everyday Oral Surgery on Instagram — https://www.instagram.com/everydayoralsurgery/ Everyday Oral Surgery on Facebook — https://www.facebook.com/EverydayOralSurgery/Dr. Grant Stucki Email — grantstucki@gmail.comDr. Grant Stucki Phone — 720-441-6059

No amount of tooling makes an organization go faster or do better. AI has made that clearer than anything else I’ve watched in nine years of doing this. What it has produced instead is what people are now calling the human wreckage of AI. How I Met Angela Dugan So one day I’m cruising around LinkedIn, in a market where nobody can get hired and companies swear they can’t find anyone, and here’s someone doing something simple. She posted about a role she wasn’t hiring for. Didn’t have the requisition, and said so right in the post. It felt awkward, it felt vulnerable…and she put it up anyway, Because she wasn’t willing to wait until she desperately needed somebody before she started meeting people. She got dozens of replies in days. Almost every one of them said the same thing. “It’s a relief to talk to a human.” That’s Angela Dugan. She’s VP of Product Delivery at Red Foundry in Chicago, and she went first while everyone else was feeding resumes into a machine. Stop Looking For Your Past Roles You’ll hear about the advice that ended her own job search, which is the part I want you to sit with: stop looking for your past roles. Look for the activities you want to do, the outcomes you want to drive, the impact you want to have. She stopped hunting for anything with “agile” in the title. That’s how she got a director job at Microsoft, and the VP job she has now. She shares the story of her layoff. She was cut from Microsoft when the AI money started moving and the people money stopped. Two days later she left a comment on somebody else’s post. Not an ask, just empathy for someone in the same wave. And her future CEO saw it. Someone she’d consulted for back in 2014 and never stopped talking to. Ten years of keeping one relationship warm. That’s the whole story. The Human Side of Business and Tech This episode is about the human side of tech, AI and Agile. Right now the job market is breaking, but it won’t stay that way. Know why? Because results speak. And what we learn from Angela Dugan is that doing things the right way (which could mean leveraging AI, but not just throwing tasks carelessly over the fence to AI) gets noticed. Because the RIGHT people make impact. They touch the bottom line. And isn’t that what we’ve been talking about here on Badass Agile? Outcomes. Not frameworks, nor conventions. Not fashion or trends or fast money. Find Angela Dugan: LinkedIn – https://www.linkedin.com/in/andugan/ (Put a note in the request.) She’s also at the local Chicago events and at VS Live. Show Notes **FORGE GENESIS IS HERE** All the skills you need to stop relying on job postings and start enjoying the freedom of an Agile career on YOUR terms. First cohort starts in Q1 2026 https://learning.fusechamber.com/forge-genesis **THE ALL NEW FORGE LIGHTNING** 12 Weeks to elite leadership! https://learning.fusechamber.com/forge-lightning **CHECK OUT ALL MY PRODUCTS AND SERVICES HERE:** https://learning.fusechamber.com We’re also on YouTube! Follow the podcast, enjoy some panel/guest commentary, and get some quick tips and guidance from me: https://www.youtube.com/c/BadassAgilea ****** Follow The LinkedIn Page: https://www.linkedin.com/showcase/badass-agile ****** Our mission is to create an elite tribe of leaders who focus on who they need to become in order to lead and inspire, and to be the best agile podcast and resource for effective mindset and leadership game. Contact us (contact@badassagile.com) for elite-level performance and agile coaching, speaking engagements, team-level and executive mindset/agile training, and licensing options for modern, high-impact, bite-sized learning and educational content.

1 Samuel 13 from our series, Heart Over Hype.

Ben Criddle talks BYU sports every weekday from 2 to 6 pm.Today's Host: Ben Criddle (@criddlebenjamin) and Co-Hosts: Subscribe to the Cougar Sports with Ben Criddle podcast: Apple Podcasts: https://itunes.apple.com/us/podcast/cougar-sports-with-ben-criddle/id99676

The White House's Office of Science and Technology Policy recently released "Science: A New Golden Age", a sweeping report that calls for a fundamental reimagining of how the United States funds and conducts science. Explicitly modeled on Vannevar Bush's landmark 1945 report "Science, the Endless Frontier," it challenges the traditional linear model of innovation, advocates for empowering individual scientists over institutions, proposes faster grants with less bureaucracy, and envisions a greater role for AI in the scientific process. But this ambitious vision arrives in a deeply contradictory context: the same administration has proposed slashing science agency budgets, cutting new NSF funding awards by over 50%, and imposing new bureaucratic controls on scientific grants. Casey Dreier is joined by Zach Pirtle, deputy director of the Consortium for Science, Policy and Outcomes at Arizona State University, and the Planetary Society's Chief of Advocacy Jack Kiraly to unpack the report's proposals, tensions, and implications. Discover more at: https://www.planetary.org/planetary-radio/space-policy-edition-science-a-new-golden-ageSee omnystudio.com/listener for privacy information.

What happens when patients living with chronic pain do not have a pain pharmacist on their healthcare team? In this episode of This Week in Pharmacy, we explore the hidden clinical, emotional, and financial costs of managing pain without a pharmacist trained in pain management. These pharmacists do far more than review medications—they serve as accessible patient advocates, medication experts, care coordinators, and trusted partners for people navigating the complexities of chronic pain. Segment One: Pharmacists Are the Secret Weapon in Pain Management Special guest host Dr. Sing Ping Chow, PharmD, BCPMP, is joined by Dr. Matthew Hermenau, PharmD, BCPMP, CPh, NBC-HWC, CPT, for an important discussion about pharmacist-led pain management. Together, they examine how pain pharmacists can: Identify medication-related risks and opportunities to improve therapy Help patients balance pain relief, function, safety, and quality of life Collaborate with prescribers and other members of the healthcare team Support individualized, evidence-informed treatment plans Educate and empower patients living with chronic pain Advocate for patients whose concerns may otherwise go unheard Address the whole person—not simply a diagnosis or pain score The conversation reinforces a powerful message: pharmacists are one of healthcare's most underused resources in chronic pain care. When a pain pharmacist is part of the team, patients gain a knowledgeable advocate who understands medications, listens to their lived experiences, and helps them pursue safer and more effective care. Remembering Dr. Jeffrey Fudin This episode includes a special tribute to the late Dr. Jeffrey Fudin, PharmD, widely regarded as pharmacy's godfather of pharmacist-led pain management. Dr. Fudin was a pioneering clinician, educator, author, mentor, and tireless advocate for the meaningful inclusion of pharmacists in pain care. His work challenged conventional thinking, elevated the role of the pharmacist, and helped build a path for future generations of pain-management specialists. His influence continues through the pharmacists he mentored, the patients he championed, and the profession he inspired. We honor Dr. Fudin's legacy and his unwavering belief that people living with pain deserve informed, compassionate, and individualized care. Segment Two: The Nation's Best Hospital Systems In the second segment, we welcome Chelsey Wen, Senior Health Data Analyst with U.S. News & World Report, to discuss the newly released 2026–2027 Best Hospitals rankings. Chelsey explains how U.S. News evaluates hospital performance and how patients and families can use the findings when making healthcare decisions. The latest assessment evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions. It places increased emphasis on patient outcomes and introduces regional specialty rankings designed to help patients locate complex care closer to home. Explore the 2026–2027 Best Hospitals announcement. link: https://health.usnews.com/best-hospitals Topics include: What it means for a hospital to be nationally ranked or rated “High Performing” The clinical data and patient outcomes considered in the evaluation Changes to the 2026–2027 rankings and methodology The importance of regional rankings and access to specialized care How patients should interpret hospital rankings when choosing where to receive care Sponsored By Today's episode of This Week in Pharmacy is brought to you by First Databank and Outcomes, pharmacy-technology organizations supporting safer, smarter, and more connected healthcare.

Casey Dreier is joined by Zach Pirtle, deputy director of the Consortium for Science, Policy and Outcomes at Arizona State University, and the Planetary Society's Chief of Advocacy Jack Kiraly to dissect the White House's "Science: A New Golden Age" report, which calls for a sweeping reimagining of how the U.S. funds and conducts science.

Nick Kostos opens the show talking Colts after they signed Jonathon Taylor to a 2-year extension. What is the team's upside for this season?

Burnout, energy management, and decision fatigue are at the center of this conversation with Liane Davey, organizational psychologist and the "teamwork doctor."Liane Davey is a New York Times bestselling author and CEO advisor with 25+ years researching what makes teams work. Her latest book, Thoughtload: Manage the Madness and Free Your Team to Do Great Work, argues the number we've been tracking wrong all along isn't workload — it's the mental and emotional weight underneath it. She previously joined the show to talk conflict; this time she's back with the framework underneath the exhaustion itself.In this conversation, we cover:The Thought Load Equation: cognitive demands plus emotional burden, divided by your energy reserves — and why managers can see your workload but not this.AI and the Hidden Cost: why offloading tasks to AI hasn't lightened the load — it's shifted the hard part to judgment and discernment, and added new anxieties of its own.Output vs. Outcomes: the trap of chasing productivity (did I produce?) instead of effectiveness (did I move the needle?) — and why AI makes this trap worse, not better.Three To-Do Lists, Not One: Liane's system for separating your quest, helping others, and side quests — and matching each to the right hours of your day.Emotions Aren't the Problem, the Story Is: the "dragon and treasure" framework for catching an emotional spiral before it becomes a 2 a.m. spiral, plus why rest alone doesn't cure burnout.This one's for anyone who's done everything the productivity playbook told them to do and still feels like they're drowning. Liane's central point lands right at this show's: winning back your thinking time and energy isn't the finish line — it's what lets you show up for the rest of your life. Get the book and take the free thought load assessment at thoughtload.com.Related episode: Ep 261 — Conflict: Productive Conflict and How to Make Disagreement Work for You — Liane's first appearance on the show, on fighting well at work.Connect with Liane Davey:LinkedInWebsiteThoughtload AssessmentThis Podcast is Powered By:Brain.fm - 20% off your first monthDescriptDescript 101CastmagicEcammPodpageRodecaster ProSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome to today's Guided Prayer, where we invite you to find a quiet space to still your mind and body.  Guided Prayers are a daily 5–10 minute, intentionally created moment to slow down and meet with God—through scripture, reflection, and honest prayer.It's not a program you attend.It's a pathway you practice.A guided space where people can stop, breathe, and connect with Jesus—every single day.

If God knows the future, why would He create someone who will ultimately reject Him?This is one of the deepest questions in Christian theology, and one that was asked by a 15​-year-old Orthodox Christian. In this episode, Nathan Jacobs​ reads one of his favorite theological letters, exploring how the Eastern Church Fathers—especially St. John of Damascus—approach God's​ foreknowledge, human freedom, divine goodness, and the mystery of damnation.Rather than offering a simplistic answer, this discussion challenges many common assumptions​ about God's knowledge of the future and reveals a​ profoundly hopeful vision of God's unwavering love for every person He creates.======================================Timestamps00:00 Introduction01:48 A Letter to Agatha02:39 The Common Assumption About Damnation04:20 The Eastern Church Fathers' Answer05:10 Why We Exist07:03 God's Knowledge and Creation08:51 Why God Doesn't "Choose the Saved"09:27 Why Not Simply Avoid Creating the Damned?11:04 God Always Chooses the Good12:08 Outcomes vs. Goodness14:44 King Saul and Divine Justice16:26 The "Future Hitler" Thought Experiment18:11 Free Will and God's Omnipotence19:27 Can God Make a Square Circle?21:55 Abraham and Isaac24:20 Damnation Is the Creature's Choice25:20 Christ's Victory Over Hades27:18 A Prison Without Bars29:01 Hope for Universal Salvation?30:30 St. Sophrony's Final Reflection======================================Do you like this content? Join Jacobs Premium to get exclusive access to essays, lecture series, monthly Q&A Zoom calls, and ourbook club. Use code: LEWIS to get a discount: https://www.thenathanjacobspodcast.com/Support the East West Series: http://theeastwestseries.com/======================================Relevant Links:God's Omnipotence Explained: Can God Really Do Anything? https://youtu.be/qEYzy1Wbjcg ​From Heretic to Orthodox: https://youtu.be/cWcVOvEu7dM​ On Apokatastasis and Universal Salvation: https://open.substack.com/pub/nathanajacobs/p/on-apokatastasis-and-universal-salvation?utm_campaign=post-expanded-share&utm_medium=webAll links:The Theological Letters (Substack): https://nathanajacobs.substack.com/Instagram: https://www.instagram.com/thenathanjacobspodcastX: https://x.com/NathanJacobsPodFacebook: https://www.facebook.com/nathanandrewjacobsAcademia: https://vanderbilt.academia.edu/NathanAJacobsListen and please review the podcast elsewhere:Spotify: https://open.spotify.com/show/0hSskUtCwDT40uFbqTk3QSApple Podcast: https://podcasts.apple.com/us/podcast/the-nathan-jacobs-podcast

In this episode, Vicki sits down with Marissa Mosunich — neuro complex career coach, founder of Operate Well Consulting and Brave Zebra Work Coaching, and someone who is living the same questions on a slightly different timeline.Marissa was diagnosed AuDHD at 34, just last year. She's taken her background in organizational management and her own lived experience and built a coaching practice that helps neurocomplex people navigate career pivots, workplace challenges, and the slow, practical work of building a professional life that actually fits.They talk about why high-achieving women are so chronically late-diagnosed, what high masking costs over a lifetime, and what it looks like to start recognizing your own needs after decades of performing competence. Marissa also reads a poem she wrote called Outcomes — about the experience of unmasking, layer by layer, the spine finally understanding what it carries.ABOUT MARISSAMarissa Mosunich is a neuro affirming work coach and organizational consultant based on California's Central Coast. She founded Operate Well Consulting and Brave Zebra Work Coaching to support neurocomplex professionals in building sustainable careers that honor how their brains actually work.Operate Well Consulting: https://operate-well.ghost.io/Brave Zebra Work Coaching: https://operate-well.ghost.io/brave-zebra-work-coaching/Instagram: @brave.zebraMENTIONED IN THIS EPISODELindsey Mackereth — therapist, researcher, and founder of the neurocomplexity framework.Lindsey's Substack: https://lindseymackereth.substack.com/SUPPORT THE SHOWIf this episode resonated with you, share it with someone who might need it.Hat on a Hat on a Hat (Substack): https://ahatonahatonahat.substack.com/Donations are gratefully accepted and help keep this show going at whatever pace is sustainable.Buy Me a Coffee: https://buymeacoffee.com/vickipeterson✍️ Subscribe now to hear future episodes.

In Part 2, we transitioned to a journal club featuring two impactful recent publications on astigmatism management. Dr. Sella reviews a randomized clinical trial comparing femtosecond laser arcuate keratotomy (FLAK) versus toric intraocular lens implantation for the correction of corneal astigmatism during cataract surgery, followed by a discussion of toric intraocular lens calculations in eyes with corneal ectasia, highlighting the unique challenges of achieving accurate refractive outcomes in patients with irregular corneas. Together, both episodes combine expert perspective with the latest clinical evidence, offering practical insights into contemporary cataract and refractive surgery. Whether you are a resident, comprehensive ophthalmologist, anterior segment surgeon, or simply interested in advances in ophthalmology, we hope you enjoy both parts of this special series. Subscribe to the podcast:  https://MayoClinicOphthalmology.podbean.com   Follow and reach out to us on X and IG: @mayocliniceye

On this episode, Carol Flagg is joined by Saul Marquez, Founder and CEO of Outcomes Rocket. Saul recently led a survey of more than 800 marketing professionals to better understand how organizations are using podcasts as part of their marketing strategy, what's driving results, where challenges remain, and how podcast content may play a growing role in an AI-driven future. He joins Carol to discuss the findings from that research and explore why podcasts continue to emerge as a powerful tool for thought leadership, audience engagement, and business growth. Access the survey here: https://www.outcomesrocket.com/insights/podcasts-as-a-marketing-powerhouse-strategies-impact-and-future-outlook-2026

Is true healing after infidelity really possible? When trust is shattered by betrayal, the pain often feels insurmountable—turning love and certainty into confusion, grief, and self-doubt. The world seems to shift on its axis, leaving many to quietly question whether relationships can ever fully recover or whether individuals can truly reclaim safety and a sense of self after such a rupture. In this episode, listeners will discover compassionate guidance for facing the aftermath of intimate betrayal and pathways toward real healing. The conversation explores why facing uncomfortable truths is a necessary starting point, what it means to rebuild safety and internal clarity, and how to find empowerment amidst pressure from others and oneself. Moving through foundational steps and the common phases of recovery, this episode offers both validation and tools for anyone unsure of what comes next—reminding listeners that, with intentional effort, hope and growth are within reach. Tammy Gustafson, MA, LPC, is a trauma-informed licensed professional counselor, coach, and speaker with over fifteen years of experience. She holds a master's degree in counseling and is the founder and CEO of Betrayal Healing and LiveFree Counseling. She is the bestselling author of Broken to Brave: Your Courageous Act of Healing After Intimate Betrayal, and she hosts the annual Betrayal Healing Conference, an international gathering of hope and expert guidance.   Episode Highlights 03:48 The unique pain of intimate betrayal and the shattering of trust. 06:17 Navigating uncertainty: Deciding whether to stay or leave after betrayal. 10:07 The necessity and process of full disclosure in healing betrayal. 14:34 Childhood roots and the myths around blame in infidelity. 16:37 Ownership and the importance of responsibility. 22:27 Key foundations of repair: Full ownership and avoiding defensiveness. 24:56 Expressing emotions and empowering the betrayed partner. 28:14 Grieving, acceptance, and the importance of safety in the healing process. 31:51 The four phases of betrayal recovery. 35:30 Outcomes after betrayal and the possibility of growth. 37:10 Indicators of healing: Rebuilding trust and recognizing positive change. 40:07 Sustaining recovery: Shifting needs, integrity, and the journey toward growth.   Your Checklist of Actions to Take Allow Time for Clarity: Resist immediate pressure to decide whether to stay or leave; give yourself space to grieve and process before making big decisions. Seek Full Disclosure: Insist on obtaining the full truth about the betrayal, ideally with the support of a therapist who specializes in betrayal trauma. Own Your Emotions: Permit yourself to experience and express all feelings—including sadness and anger—throughout the healing process. Establish Safety: Ask yourself, "What do I need to feel safe?" and establish boundaries or environments that honor those needs. Expect 100% Ownership from the Betraying Partner: Require the partner who betrayed to take complete responsibility for both their actions and the impact on you. Look for Consistent Change: Observe for ongoing, consistent behavioral change and empathy from the betraying partner as indicators of healing. Consider Professional Support: Work with therapists individually and as a couple who are trained in betrayal and trauma to facilitate healthy communication and healing. Focus on Personal Growth: Prioritize your own healing, self-care, and post-traumatic growth, regardless of the relationship's outcome.   Mentioned Broken to Brave: Your Courageous Act of Healing After Intimate Betrayal (*Amazon Affiliate link) (book) Shifting Criticism For Connected Communication (free relationship guide)   Connect with Tammy Gustafson Website: tammygustafson.com Instagram: instagram.com/tammylgustafson Facebook: facebook.com/betrayalhealing  LinkedIn: linkedin.com/in/tammy-gustafson-lpc-4179aaa3/   

In this episode of Insights Beyond the Counter, hosts Shane Hallengren and Amit Patel unpack the rapidly evolving world of health risk assessments (HRAs) and social determinants of health (SDOH) across Medicaid and Medicare. Fresh off the Medicaid Innovations Forum, Amit shares insights from health plan leaders navigating a post–Public Health Emergency landscape defined by redeterminations, workforce shortages, and persistent challenges with member contactability. Shane reflects on his years supporting Medicare performance programs and draws parallels between the two sectors—especially around how HRAs have shifted from simple “check‑the‑box” tasks to powerful tools that uncover transportation barriers, food insecurity, medication access challenges, utility instability, and more. Together, they explore: Why SDOH data is only valuable when it leads to meaningful action How community pharmacies—as trusted, accessible care touchpoints—are uniquely positioned to conduct sensitive assessments The growing importance of rural health transformation and how pharmacies can close engagement and adherence gaps How Outcomes is supporting pharmacies with technology, workflows, and scalable programs that enable efficient, person-to-person care What the future may hold as Medicaid and Medicare strategies continue to evolve If you're passionate about healthcare innovation, population health, or the expanding role of pharmacy, this conversation is packed with real-world insights you won't want to miss.

Will Harvey got into real estate the way a lot of people do. He dropped out of college after a double hip surgery ended football, landed on a mortgage desk in 2015, and figured out fast how leverage worked. He bought his first house on a $30,000 salary with his dad as a co-signer, rented out two of the three bedrooms, and house hacked a deal before he knew the word for it.Then came the part nobody puts in the brochure. Three rentals in an expensive market, no money left, and the discovery that owning property is not passive. As Will puts it, the only genuinely passive position in real estate is limited partner, and you pay for it by giving up control.So he kept moving. He left a high-paying W2 to flip houses, rolled the flip profits into syndications, took bonus depreciation against the gains, did a couple of deals as a GP. And somewhere in there he figured out what actually excites him is the finance side of the table, not the operating side.That led to a friends-and-family fund in 2023, an accidental first hard money loan, and eventually a dedicated 506(c) fund built on a specific idea: that hard money underwriting is due for a rebuild from first principles.Will walks through the seven risks he underwrites against, why he thinks most lenders collect the wrong paperwork while skipping the single most predictive input available, and how he uses AI to compress an underwriting file from hours to about ten minutes without giving up the verification step.He also talks about the $70,000 he lost on a deal he already knew he should not have taken, what he looks for in an investor conversation before he will accept a wire, and why the boring end of real estate is the point rather than the compromise.What you will learnWhy Will chose debt over equity, and what that decision has to do with temperament rather than returnsThe first-principles exercise he ran on lending, and the seven risks it producedWhich document lenders over-collect, and which input they skip entirelyHow AI actually sits in his underwriting stack, and where he still verifies by handWhat he screens for in a first conversation with a prospective investorWhy he charges points and has no prepayment penaltyConnect with Will HarveyWebsite: harvey-capital.comEmail: will@harvey-capital.comLinkedIn: search Will Harvey, Harvey CapitalThis week's bookTitan: The Life of John D. Rockefeller, Sr. by Ron ChernowWill also mentioned The Book of Elon, a compilation of Elon Musk's own thinking pulled from interviews. He reads both the same way: printed out, at night, when his mind has slowed down enough to actually absorb it.Chapters00:00 Cold open: the first call with a borrower00:35 Welcome01:40 Who Will Harvey is and what Harvey Capital does02:27 Dropping out, double hip surgery, and the mortgage desk03:43 House hacking the first deal before he knew the term04:44 Nothing about owning rentals is passive05:29 Leaving a high-paid W2 to flip houses06:31 The realization: he is not an operator, he is a finance guy06:58 The 2023 friends-and-family fund07:50 The accidental first hard money loan08:06 Graduating from a 506(b) to a 506(c)10:02 Why debt instead of equity13:13 How he protects capital13:32 Applying SpaceX first principles to lending15:53 The seven risks he underwrites against16:25 Over-documenting what does not matter17:00 The borrower's story as the real underwriting input18:49 A word from Elevista Connect19:52 Screening investors on temperament, not just accreditation20:04 Why the one-year term filters people out21:00 Boring is the whole point23:20 Where the borrowers actually come from23:30 Google ads, and turning them off24:15 The REIA coin flip28:39 How Will uses AI to run the business28:44 Claude Code on the terminal30:40 Recording borrower calls as a data point31:52 Compressing hours of underwriting into ten minutes32:36 Incumbent lenders move like turtles33:01 Why flippers actually buy speed35:09 No prepayment penalties, and the reason why36:23 Lightning round36:52 What drives him37:50 The best advice he ever got38:25 Buffett: price and value are two different things39:40 The decision he would take back40:44 Losing $70,000 on a deal outside the buy box41:32 The return on brain damage41:52 What is on his nightstand41:58 Titan, and The Book of Elon43:33 Ed's NotebookLM workflow for books he never gets to45:55 How Will defines success46:12 Outcomes are a distraction, focus on the process47:50 You only get 18 summers48:56 How to reach Will49:03 harvey-capital.comThis has been the Real Estate Underground. Don't forget to subscribe, it helps us grow.Elevista - Speed as a Service™Elevista Connect is the first AI-powered lead conversion system built for real estate investors.

Plea bargaining shapes most criminal cases, but how does it impact justice, sentencing, and the rights of defendants?Is Plea Bargaining Broken — or the Only Thing Saving the Courts?Plea bargaining dominates the U.S. criminal justice system, but is it a necessary tool or a practice undermining justice? In this eye-opening conversation, host Steve Palmer sits down with veteran litigator Paul Scarsella, who brings the rare dual perspective of former prosecutor and current defense counsel. Together, they peel back the layers of how plea deals really work. And why every decision, from charging to negotiation, is shaped by politics, human imperfection, and the quirks of local power.In this episode, you'll learn:How politics and individual bias affect charging decisions, negotiations, and outcomes for defendantsWhy plea deals often start with higher charges. And how that impacts a defendant's ability to exercise their right to trialThe real factors that sway plea bargaining: jurisdiction, the assigned judge, and prosecutors' motivesHow legislative changes, like mandatory minimums and sentencing guidelines, can backfire and drive case outcomesWhen plea bargains make sense. And where they risk coercing innocent people to plead guiltyTakeaways:The right to a jury trial exists in theory, but risk and charging tactics often leave defendants with little practical choiceJudicial discretion and the “luck of the draw” create wide outcome disparities across counties and judgesSeparation of powers—legislative, executive (prosecution), and judicial—both protect and complicate the systemPolitics, from the local to federal level, steer prosecution priorities and sentencing lawsUltimately, plea bargaining is a byproduct of a system built by and for humans. It's flawed, but with checks and balances5 Frequently Asked Questions about Plea Bargaining1. What is plea bargaining, and why is it so common in criminal cases?Plea bargaining is the process where a defendant pleads guilty to a lesser charge (or receives a reduced sentence) to avoid trial. It's common because the volume of cases would overwhelm courts if every case went to trial 25:29.2. How do politics influence plea bargaining and prosecution decisions?Politics affect charging and negotiation, as prosecutors are often elected officials aiming to appear tough on crime, which impacts how cases are handled and settled 08:01.3. Do all defendants really have a practical choice to go to trial?Not always. Overcharging or risk of severe mandatory sentences can make the risk of trial too high, so even innocent defendants might feel pressured to accept a plea 30:33.4. How do local differences between judges and counties affect case outcomes?Outcomes vary greatly based on the county, the prosecutor's policies, and the assigned judge. There's one set of laws, but they're applied in 88 different ways in Ohio 13:19.5. Is plea bargaining inherently unfair or is it necessary?The episode argues it's complicated: plea bargaining addresses practical needs but can be abused due to overcharging and mandatory minimums. Its fairness depends on how prosecutors and judges wield their discretion 01:03:08.Submit your questions to www.lawyertalkpodcast.com.Recorded at Channel 511.Stephen E. Palmer, Esq. has been practicing criminal defense almost exclusively since 1995. He has represented people in federal, state, and local courts in Ohio and elsewhere.Though he focuses on all areas of criminal defense, he particularly enjoys complex cases in state and federal courts.He has unique experience handling and assembling top defense teams of attorneys and experts in cases involving allegations of child abuse (false sexual allegations, false physical abuse allegations), complex scientific cases involving allegations of DUI and vehicular homicide cases with blood alcohol tests, and any other criminal cases that demand jury trial experience.Steve has unique experience handling numerous high publicity cases that have garnered national attention.For more information about Steve and his law firm, visit Palmer Legal Defense. Copyright 2026 Stephen E. Palmer - Attorney At LawMentioned in this episode:Circle 270 Media Podcast ConsultantsCircle 270 Media® is a podcast consulting firm based in Columbus, Ohio, specializing in helping businesses develop, launch, and optimize podcasts as part of their marketing strategy. The firm emphasizes the importance of storytelling through podcasting to differentiate businesses and engage with their audiences effectively. www.circle270media.com

PWTorch editor Wade Keller is joined by PWTorch's Javier Machado to review WWE Smackdown with live chat and caller interactions throughout starting with a thorough discussion on the CM Punk-Cody Rhodes exchange and why it seemed effective and disciplined, but was the crowd engaged or slightly bored? Also, Nick Aldis shows fire and fight and he shares his story of going from pro wrestler to GM. Plus is Chelsea Green the dark horse to become Interim Champ? Are the Tongans with Haku too badass to be successful as heels? A full preview of the entire Summerslam line-up with thoughts on what happens afterward including potentially Kevin Owens, Randy Orton, or Drew McIntyre being a big part of the next few months.Become a supporter of this podcast: https://www.spreaker.com/podcast/wade-keller-pro-wrestling-post-shows--3275545/support.

Today we jump back 15 years to the July 13, 2011 episode of the PWTorch Livecast with host PWTorch assistant editor James Caldwell and PWTorch columnist Pat McNeill where they discussed with live callers today's battle between The Rock and John Cena, the potential Money in the Bank PPV match outcomes, why the audience WWE was marketing to is leery of ordering the PPV, the low Raw rating and whether there is concern & how WWE might use it against CM Punk, TNA talent frustrated and who might be good fits in WWE, and more. In the previously VIP-exclusive Aftershow, they looked into the McNeil Mailbag for questions on the best talkers in wrestling history, plus more.Become a supporter of this podcast: https://www.spreaker.com/podcast/wade-keller-pro-wrestling-podcast--3076978/support.

In this episode, Jason continues the IPCS series by explaining why project teams must actively support and enable designers throughout pre-construction. He covers real-time budgeting and scheduling, integrated models, design-assist trade partners, constructability reviews, and coordinated communication systems. When designers are left to work in isolation, projects are more likely to miss milestones, exceed the budget, create installation problems, and disappoint both the owner and the facilities team. What you'll learn in this episode: Why designers need active support from builders during pre-construction. How real-time budgeting and Takt planning improve design decisions. Why constructability reviews must examine real building systems and installation needs. How integrated models, meetings, communication, and stakeholders improve coordination. Why treating designers as partners helps projects finish on time and on budget. Are you giving designers the information and support they need, or leaving them to solve the project alone? If you like the Elevate Construction podcast, please subscribe for free and you'll never miss an episode.  And if you really like the Elevate Construction podcast, I'd appreciate you telling a friend (Maybe even two